Get the Stockscreener App
12.19
19.39%
1.98
After Hours:
12.19
Cryoport Inc stock is traded at $12.19, with a volume of 2.21M.
It is up +19.39% in the last 24 hours and up +39.00% over the past month.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
See More
Previous Close:
$10.21
Open:
$11
24h Volume:
2.21M
Relative Volume:
4.90
Market Cap:
$611.91M
Revenue:
$176.18M
Net Income/Loss:
$-36.26M
P/E Ratio:
-13.07
EPS:
-0.9326
Net Cash Flow:
$-28.09M
1W Performance:
+20.69%
1M Performance:
+39.00%
6M Performance:
+42.91%
1Y Performance:
+110.54%
1-Day Range:
$10.99
$12.65
1-Week Range:
$9.695
$12.65
52-Week Range:
$5.31
$12.65
Cryoport Inc Stock (CYRX) Company Profile
Name
Cryoport Inc
Sector
Industry
Phone
(949) 232-1900
Address
112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Compare CYRX vs FDX, UPS, JBHT, EXPD, CHRW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYRX
Cryoport Inc
|
12.19 | 512.52M | 176.18M | -36.26M | -28.09M | -0.9326 |
FDX
Fedex Corp
|
362.75 | 85.37B | 91.93B | 4.48B | 4.37B | 18.79 |
UPS
United Parcel Service Inc
|
98.07 | 81.83B | 88.64B | 5.57B | 4.77B | 6.5569 |
JBHT
J B Hunt Transport Services Inc
|
243.04 | 22.48B | 12.13B | 622.10M | 1.03B | 6.4596 |
EXPD
Expeditors International Of Washington Inc
|
153.08 | 18.58B | 11.07B | 812.05M | 953.40M | 5.9494 |
CHRW
C H Robinson Worldwide Inc
|
167.13 | 19.01B | 16.20B | 599.01M | 807.11M | 4.9434 |
Cryoport Inc Stock (CYRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Aug-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Overweight |
| Mar-24-25 | Upgrade | UBS | Neutral → Buy |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Aug-07-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| May-03-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| Apr-04-24 | Resumed | Jefferies | Buy |
| Mar-13-24 | Reiterated | Needham | Buy |
| Aug-17-23 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-10-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-18-23 | Downgrade | UBS | Buy → Neutral |
| Jul-17-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-13-23 | Downgrade | SVB Securities | Outperform → Market Perform |
| Jan-19-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Nov-05-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Oct-19-21 | Resumed | B. Riley Securities | Buy |
| Jul-16-21 | Initiated | BTIG Research | Buy |
| Mar-15-21 | Initiated | UBS | Buy |
| Mar-02-21 | Resumed | Needham | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-08-20 | Initiated | Stephens | Overweight |
| Jul-01-19 | Resumed | Needham | Buy |
| Oct-10-18 | Initiated | B. Riley FBR | Buy |
| Aug-13-18 | Reiterated | Cowen | Outperform |
| Jul-02-18 | Reiterated | Needham | Buy |
| Mar-08-18 | Reiterated | Needham | Buy |
| Nov-30-17 | Initiated | ROTH Capital | Buy |
| Sep-12-17 | Reiterated | Cowen | Outperform |
| Aug-31-17 | Reiterated | Needham | Buy |
| Aug-09-17 | Reiterated | Cowen | Outperform |
| Jul-26-17 | Reiterated | Needham | Buy |
| Jul-12-17 | Initiated | Janney | Buy |
| Jun-16-17 | Initiated | Cowen | Outperform |
| Jun-01-17 | Reiterated | Needham | Buy |
| Apr-03-17 | Initiated | Needham | Buy |
View All
Cryoport Inc Stock (CYRX) Latest News
Cryoport Inc. Signals Growth Momentum in Earnings Call - TipRanks
Cryoport (CYRX) lifts Q1 2026 revenue to $47.8M while trimming net loss - Stock Titan
Cryoport Posts Revenue Beat In Q1 As Clinical Trial Support Hits All-Time High — 'A Strong Start To 2026' - Sahm
CryoPort (NASDAQ:CYRX) Shares Gap Up on Analyst Upgrade - MarketBeat
MoCo Minute | Biotechnology company CaleoBio advancing stem cell-based research - AOL.com
Cryoport price target raised to $17 from $15 at BTIG - TipRanks
Cryoport Lifts Guidance, HSBC Misses on Fraud Charge - Gotrade
CryoPort (NASDAQ:CYRX) Price Target Raised to $15.00 - MarketBeat
CryoPort (NASDAQ:CYRX) Price Target Raised to $17.00 - MarketBeat
Cryoport price target raised to $12 from $11 at Guggenheim - TipRanks
Cryoport, Inc. (NASDAQ:CYRX) Q1 2026 Earnings Call Transcript - Insider Monkey
Needham raises CryoPort stock price target to $15 on revenue beat - Investing.com
BTIG raises CryoPort stock price target to $17 on strong results By Investing.com - Investing.com South Africa
Cryoport Reports 16% Revenue Growth in Q1 2026, Raises Full-Year Guidance and Highlights Record Cell & Gene Therapy Support - Minichart
BTIG raises CryoPort stock price target to $17 on strong results - Investing.com Canada
Cryoport projects $192M-$196M FY 2026 revenue and expects positive adjusted EBITDA in 2H 2026 - MSN
Cryoport Q1 FY2026 slides: 16% revenue growth drives raised guidance By Investing.com - Investing.com Australia
Cryoport posts revenue beat in Q1 as clinical trial support hits all-time high — 'A strong start to 2026' - MSN
Cryoport, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
CryoPort Q1 2026 earnings preview - MSN
Cryoport Q1 FY2026 slides: 16% revenue growth drives raised guidance - Investing.com
CryoPort Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Cryoport Q1 2026 misses EPS but raises revenue guidance - Investing.com Australia
Cryoport reports Q1 EPS (25c), consensus (19c) - TipRanks
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Cryoport, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CYRX) 2026-05-04 - Seeking Alpha
Cryoport Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CryoPort (NASDAQ:CYRX) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Cryoport (CYRX) Q1 2026 Earnings Transcript - The Globe and Mail
Cryoport Inc (NASDAQ:CYRX) Reports Q1 2026 Revenue Beat Amid Wider Net Loss and Cautious Full-Year Outlook - ChartMill
Cryoport (CYRX) Q2 2025 Earnings Transcript - AOL.com
Cryoport reports Q1 2026 revenue up 16% to $47.8M, raises full-year guidance - TradingView
Cryoport (CYRX) Q3 2025 Earnings Transcript - AOL.com
CRYOPORT ($CYRX) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
BRIEF-Cryoport Q1 Gross Margin 45.8% - TradingView
Cryoport, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
How The Cryoport (CYRX) Story Is Shifting With Fresh Analyst Coverage And Valuation Tweaks - Yahoo Finance
CryoPort Q1 2026 Earnings Call Transcript - MarketBeat
CryoPort (NASDAQ:CYRX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Cryoport Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
CryoPort (CYRX) Set to Release Q1 Earnings on May 4 with Mixed E - GuruFocus
Earnings Preview: Cryoport to Report Financial Results Post-market on May 04 - Moomoo
Cryoport to Report First Quarter 2026 Financial Results on May 4 - GuruFocus
Discipline and Rules-Based Execution in CYRX Response - Stock Traders Daily
CryoPort, Inc. (CYRX) reports Q4 loss, tops revenue estimates - MSN
CryoPort (CYRX) Projected to Post Earnings on Monday - MarketBeat
Craig-Hallum initiates coverage of Cryoport (CYRX) with buy recommendation - MSN
CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know - MSN
CryoPort (NASDAQ:CYRX) Stock Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
CryoPort (NASDAQ:CYRX) Upgraded at Wall Street Zen - MarketBeat
CYRX Price Today: CryoPort, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Cryoport Inc Stock (CYRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):